PRLD Short-Mid Term Analysis

NASDAQ:PRLD   Prelude Therapeutics Incorporated
It may pullback from this level before going up again.

Not financial advice, do your own DD all the time.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.